Evidence map›Paper›PMID 32929119›Full record

ArticleScientific reports2020

A customized scaffolds approach for the detection and phasing of complex variants by next-generation sequencing.

Qiandong Zeng, Natalia T Leach, Zhaoqing Zhou, Hui Zhu, Jean A Smith, Lynne S Rosenblum, Angela Kenyon, Ruth A Heim, Marcia Eisenberg, Stanley Letovsky and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2024
    Review
  3. Next-Generation Sequencing Analysis ofFrontiers in genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Qiandong ZengIntegrated Genetics, Laboratory Corporation of America Holdings, 3400 Computer Dr., Westborough, MA, USA. zengq@labcorp.com.
Natalia T LeachIntegrated Genetics, Laboratory Corporation of America Holdings, 3400 Computer Dr., Westborough, MA, USA.
Zhaoqing ZhouIntegrated Genetics, Laboratory Corporation of America Holdings, 3400 Computer Dr., Westborough, MA, USA.
Hui ZhuIntegrated Genetics, Laboratory Corporation of America Holdings, 3400 Computer Dr., Westborough, MA, USA.
Jean A SmithIntegrated Genetics, Laboratory Corporation of America Holdings, 3400 Computer Dr., Westborough, MA, USA.
Lynne S RosenblumIntegrated Genetics, Laboratory Corporation of America Holdings, 3400 Computer Dr., Westborough, MA, USA.
Angela KenyonIntegrated Genetics, Laboratory Corporation of America Holdings, 3400 Computer Dr., Westborough, MA, USA.
Ruth A HeimCenter for Molecular Biology and Pathology, Laboratory Corporation of America Holdings, 1912 T.W. Alexander Dr., Research Triangle Park, Durham, NC, USA.
Marcia EisenbergCenter for Molecular Biology and Pathology, Laboratory Corporation of America Holdings, 1912 T.W. Alexander Dr., Research Triangle Park, Durham, NC, USA.
Stanley LetovskyIntegrated Genetics, Laboratory Corporation of America Holdings, 3400 Computer Dr., Westborough, MA, USA.
Patricia M OkamotoIntegrated Genetics, Laboratory Corporation of America Holdings, 3400 Computer Dr., Westborough, MA, USA. okamotp@labcorp.com.
Sequenom (United States) · USLabCorp (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Next-generation sequencing (NGS) is widely used in genetic testing for the highly sensitive detection of single nucleotide changes and small insertions or deletions. However, detection and phasing of structural variants, especially in repetitive or homologous regions, can be problematic due to uneven read coverage or genome reference bias, resulting in false calls. To circumvent this challenge, a computational approach utilizing customized scaffolds as supplementary reference sequences for read alignment was developed, and its effectiveness demonstrated with two CBS gene variants: NM_000071.2:c.833T>C and NM_000071.2:c.[833T>C; 844_845ins68]. Variant c.833T>C is a known causative mutation for homocystinuria, but is not pathogenic when in cis with the insertion, c.844_845ins68, because of alternative splicing. Using simulated reads, the custom scaffolds method resolved all possible combinations with 100% accuracy and, based on > 60,000 clinical specimens, exceeded the performance of current approaches that only align reads to GRCh37/hg19 for the detection of c.833T>C alone or in cis with c.844_845ins68. Furthermore, analysis of two 1000 Genomes Project trios revealed that the c.[833T>C; 844_845ins68] complex variant had previously been undetected in these datasets, likely due to the alignment method used. This approach can be configured for existing workflows to detect other challenging and potentially underrepresented variants, thereby augmenting accurate variant calling in clinical NGS testing.

Indexed as

MutationAlternative SplicingCystathionine beta-SynthaseGenetic TestingGenome-Wide Association StudyHigh-Throughput Nucleotide SequencingHumansPolymorphism, Single NucleotideSequence Analysis, DNACystathionine beta-Synthase

Identifiers

PMID32929119
PMCPMC7490669
OpenAlexW3085536280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.